Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Fortaz (ceftazidime) Injection, Fortaz (ceftazidime sodium) Injection, Ceptaz (ceftazidime) Injection (L-arginine formulation), GlaxoSmithKline NDA 50-578/S-040, 50-634/S-012 & 50-646/S14 3/29/02 4/8/02 3/29/02 Fortaz (ceftazidime sodium) Injection Fortaz (ceftazidime) Injection, GlaxoSmithKline NDA 50-578/S-042 & 50-634/S-014 CEFTAZIDIME Injection 1GM/VIAL TAZICEF Abbott 064032 CEFTAZIDIME Injection 1GM/VIAL TAZICEF Abbott 064032 CEFTAZIDIME Injection 2GM/VIAL TAZICEF Abbott 062662 CEFTAZIDIME Injection 2GM/VIAL TAZICEF Abbott 062662 CEFTAZIDIME Injection 500MG/VIAL TAZICEF Abbott 062662 CEFTAZIDIME Injection 6GM/VIAL TAZICEF Abbott 050578 CEFTAZIDIME Injection 1GM/VIAL FORTAZ GLAXOSMITHKLINE 050578 CEFTAZIDIME Injection 2GM/VIAL FORTAZ GLAXOSMITHKLINE 050578 CEFTAZIDIME Injection 500MG/VIAL FORTAZ GLAXOSMITHKLINE 050578 CEFTAZIDIME Injection 6GM/VIAL FORTAZ GLAXOSMITHKLINE 062640 CEFTAZIDIME Injection 1GM/VIAL TAZIDIME LILLY 062655 CEFTAZIDIME Injection 1GM/VIAL TAZIDIME LILLY 062655 CEFTAZIDIME Injection 2GM/VIAL TAZIDIME LILLY 062640 CEFTAZIDIME Injection 2GM/VIAL TAZIDIME LILLY 062640 CEFTAZIDIME Injection 500MG/VIAL TAZIDIME LILLY 050646 CEFTAZIDIME (ARGININE FORMULATION) Injection 10GM/VIAL CEPTAZ GLAXOSMITHKLINE 050646 CEFTAZIDIME (ARGININE FORMULATION) Injection 1GM/VIAL CEPTAZ GLAXOSMITHKLINE 050646 CEFTAZIDIME (ARGININE FORMULATION) Injection 2GM/VIAL CEPTAZ GLAXOSMITHKLINE 063221 CEFTAZIDIME SODIUM Injection 10MG BASE/ML CEFTAZIDIME SODIUM IN PLASTIC CONTAINER Baxter 063221 CEFTAZIDIME SODIUM Injection 20MG BASE/ML CEFTAZIDIME SODIUM IN PLASTIC CONTAINER Baxter 063221 CEFTAZIDIME SODIUM Injection 40MG BASE/ML CEFTAZIDIME SODIUM IN PLASTIC CONTAINER Baxter | 050634 CEFTAZIDIME SODIUM Injection 20MG BASE/ML FORTAZ IN PLASTIC CONTAINER GLAXOSMITHKLINE | 050634 CEFTAZIDIME SODIUM Injection 40MG BASE/ML FORTAZ IN PLASTIC CONTAINER GLAXOSMITHKLINE | Fortaz (ceftazidime for injection), Glaxo Group Limited | Fortaz (ceftazidime sodium injection), Glaxo Group Limited | FORTAZ (ceftazidime) Injectable, GlaxoSmithKline, Labeling Revision | FORTAZ (ceftazidime) Injection, GlaxoSmithKline, Labeling Revision | Fortaz (ceftazidime) Injection, GlaxoSmithKline, Labeling Revision | Fortaz (ceftazidime sodium) I.V. Solution, GlaxoSmithKline, Labeling Revision | Ceftazidime Injection, Wockhardt Ltd., Approval ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem.com